Upon coincubation with natural killer (NK) cells, these AML-blast EVs efficiently downregulated the expression of surface NKG2D (an activator of NK cells) indicating a possible function in mediating immunosuppression in AML [123]. Here, KLRK1 is linked to acute myeloid leukemia.